Thursday
SESSION XII: NEW DEVELOPMENTS IN SFA AND CRURAL ARTERY TREATMENTS: THE STATE-OF-THE-ART AND NEW ADJUNCTS (6-MINUTE TALKS)
Moderators:Enrico Ascher, M.D. , Götz M. Richter, M.D., Ph.D.
SESSION XII SCHEDULE
10:18 AM - 10:24 AM Biomechanical Bases For Treatment Of SFA Disease: Factors Involving Stents And The Artery: Can They Be Resolved And How To Design The Perfect Stent For The SFA
  Presenters(s): Daniel Y. Sze, M.D., Ph.D.  
10:25 AM - 10:31 AM Debate: Late Results With The Silverhawk Device: Rotational Atherectomy For Infrainguinal Arteriosclerosis Is A Good Thing
  Presenters(s): Venkatesh G. Ramaiah, M.D.  
10:32 AM - 10:38 AM Debate: Durability Of Treatment With The Silverhawk Atherectomy Device: Why It Has Limited Value
  Presenters(s): Timur P. Sarac, M.D.  
10:39 AM - 10:45 AM Present And Future Of Endovascular SFA Treatment: Stents, Stent-Grafts, Drug Coated Balloons And Drug Coated Stents: What’s On The Horizon?
  Presenters(s): Marc Bosiers, M.D.  
10:46 AM - 10:52 AM New Concepts In Atherectomy Devices And Stents And Their Role In Tibial Artery Disease: Will Drug Eluting Stents Help?
  Presenters(s): Dierk Scheinert, M.D.  
10:53 AM - 10:59 AM How Good Are Present Stents In The SFA And Popliteal Arteries: Will Bioabsorbable Stents Or New Lasers (Turbobooster) Help?
  Presenters(s): Giancarlo Biamino, M.D.  
11:00 AM - 11:06 AM Limits Of Endovascular Treatment Of Femoropopliteal Occlusive Disease: Gender, Diabetes, Calcification And Aneurysmal Disease Make A Difference: What Is The Need For Embolic Protection?
  Presenters(s): Klaus D. Hagspiel, M.D.  
11:07 AM - 11:13 AM Late Results (3-5 Years) With Zilver Plain Nitinol Stents For TASC C & D SFA Lesions
  Presenters(s): Marcelo Ferreira, M.D.  
11:14 AM - 11:20 AM Will Drug Eluting Stents Do Better In The SFA: Results With The Cook Zilver PTX Drug Coated Stent Without A Polymer
  Presenters(s): Michael D. Dake, M.D.  
11:21 AM - 11:27 AM Results With The Edwards Life Stent For Femoropopliteal Occlusive Disease: Does The Stent Make A Difference In This Difficult Location: The RESILIENT Trial Results
  Presenters(s): Barry T. Katzen, M.D.  
11:28 AM - 11:35 AM Panel Discussion
END OF SESSION XII